XFCI yields 2000000.00% · PFE yields 6.13%● Live data
📍 XFCI pulled ahead of the other in Year 1
Combined, XFCI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XFCI + PFE for your $10,000?
Xtreme Fighting Championships, Inc. operates as a sports entertainment and media company. The company produces a range of live fighting events that are broadcast through traditional networks, pay-per-view, and online. It engages in the mixed martial arts (MMA) league businesses. The company produces and promotes live XFC fighting events featuring a range of MMA fighters in all major weight classes for men and women; provides talent development services; and develops advertising and sponsorship programs that would extend live events to broadcast and social media content. It is also involved in broadcasting and promoting events on various traditional and internet media; and developing merchandise to promote the company's XFC brand among consumers and MMA sports enthusiasts. The company was formerly known as Duke Mountain Resources, Inc. and changed its name to Xtreme Fighting Championships, Inc. in July 2020. Xtreme Fighting Championships, Inc. was incorporated in 2006 and is headquartered in Miramar Beach, Florida.
Full XFCI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.